Cinclus Pharma (CINPHA) — Net Asset Quality Index
Cinclus Pharma (CINPHA) has a Net Asset Quality Index of 47.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr424.54 Million minus total liabilities of Skr221.84 Million yields net assets of Skr202.70 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Cinclus Pharma (CINPHA) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Cinclus Pharma Net Asset Quality Index Over Time (2022–2025)
This chart shows how Cinclus Pharma's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the index stands at 47.7%, representing net assets of Skr202.70 Million against total assets of Skr424.54 Million SEK. For live market cap and overall valuation, see CINPHA stock market capitalisation.
Annual Net Asset Quality Index for Cinclus Pharma (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for Cinclus Pharma from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Cinclus Pharma (CINPHA) shareholders funds for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.6% | Skr369.39 Million | Skr546.56 Million | Skr177.16 Million | ▼ -24.8 pp |
| 2024 | 92.4% | Skr555.33 Million | Skr601.01 Million | Skr45.68 Million | ▲ +173.7 pp |
| 2023 | -81.3% | Skr-76.80 Million | Skr94.41 Million | Skr171.21 Million | ▼ -149.6 pp |
| 2022 | 68.3% | Skr126.87 Million | Skr185.77 Million | Skr58.90 Million | — |